1 Introduction to Research & Analysis Reports 1.1 Sulphonamides Market Definition 1.2 Market Segments 1.2.1 Segment by Type 1.2.2 Segment by Application 1.3 United States Sulphonamides Market Overview 1.4 Methodology & Sources of Information 1.4.1 Research Methodology 1.4.2 Research Process 1.4.3 Base Year 2 United States Sulphonamides Overall Market Size 2.1 United States Sulphonamides Market Size: 2021 VS 2027 2.2 United States Sulphonamides Revenue, Prospects & Forecasts: 2016-2027 2.3 United States Sulphonamides Sales: 2016-2027 3 Company Landscape 3.1 Top Sulphonamides Players in United States Market 3.2 Top United States Sulphonamides Companies Ranked by Revenue 3.3 United States Sulphonamides Revenue by Companies 3.4 United States Sulphonamides Sales by Companies 3.5 United States Sulphonamides Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Sulphonamides Companies in United States Market, by Revenue in 2020 3.7 Manufacturers Sulphonamides Product Type 3.8 Tier 1, Tier 2 and Tier 3 Sulphonamides Players in United States Market 3.8.1 List of Tier 1 Sulphonamides Companies in United States 3.8.2 List of Tier 2 and Tier 3 Sulphonamides Companies in United States 4 Sights by Type 4.1 Overview 4.1.1 By Type - United States Sulphonamides Market Size Markets, 2021 & 2027 4.1.2 Orally Absorbable Sulfonamide 4.1.3 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) 4.1.4 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) 4.2 By Type - United States Sulphonamides Revenue & Forecasts 4.2.1 By Type - United States Sulphonamides Revenue, 2016-2021 4.2.2 By Type - United States Sulphonamides Revenue, 2022-2027 4.2.3 By Type - United States Sulphonamides Revenue Market Share, 2016-2027 4.3 By Type - United States Sulphonamides Sales & Forecasts 4.3.1 By Type - United States Sulphonamides Sales, 2016-2021 4.3.2 By Type - United States Sulphonamides Sales, 2022-2027 4.3.3 By Type - United States Sulphonamides Sales Market Share, 2016-2027 4.4 By Type - United States Sulphonamides Price (Manufacturers Selling Prices), 2016-2027 5 Sights by Application 5.1 Overview 5.1.1 By Application - United States Sulphonamides Market Size, 2021 & 2027 5.1.2 Skin Infections 5.1.3 Gastro Intestinal Tract (GIT) Infection 5.1.4 Meningitis 5.2 By Application - United States Sulphonamides Revenue & Forecasts 5.2.1 By Application - United States Sulphonamides Revenue, 2016-2021 5.2.2 By Application - United States Sulphonamides Revenue, 2022-2027 5.2.3 By Application - United States Sulphonamides Revenue Market Share, 2016-2027 5.3 By Application - United States Sulphonamides Sales & Forecasts 5.3.1 By Application - United States Sulphonamides Sales, 2016-2021 5.3.2 By Application - United States Sulphonamides Sales, 2022-2027 5.3.3 By Application - United States Sulphonamides Sales Market Share, 2016-2027 5.4 By Application - United States Sulphonamides Price (Manufacturers Selling Prices), 2016-2027 6 Manufacturers & Brands Profiles 6.1 Abbott Laboratories 6.1.1 Abbott Laboratories Corporation Information 6.1.2 Abbott Laboratories Overview 6.1.3 Abbott Laboratories Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.1.4 Abbott Laboratories Sulphonamides Product Description 6.1.5 Abbott Laboratories Recent Developments 6.2 Boehringer Ingelheim Pharmaceuticals 6.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information 6.2.2 Boehringer Ingelheim Pharmaceuticals Overview 6.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Description 6.2.5 Boehringer Ingelheim Pharmaceuticals Recent Developments 6.3 Bayer AG 6.3.1 Bayer AG Corporation Information 6.3.2 Bayer AG Overview 6.3.3 Bayer AG Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.3.4 Bayer AG Sulphonamides Product Description 6.3.5 Bayer AG Recent Developments 6.4 GlaxoSmithKline 6.4.1 GlaxoSmithKline Corporation Information 6.4.2 GlaxoSmithKline Overview 6.4.3 GlaxoSmithKline Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.4.4 GlaxoSmithKline Sulphonamides Product Description 6.4.5 GlaxoSmithKline Recent Developments 6.5 King Pharmaceuticals 6.5.1 King Pharmaceuticals Corporation Information 6.5.2 King Pharmaceuticals Overview 6.5.3 King Pharmaceuticals Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.5.4 King Pharmaceuticals Sulphonamides Product Description 6.5.5 King Pharmaceuticals Recent Developments 6.6 Mylan Pharmaceuticals 6.6.1 Mylan Pharmaceuticals Corporation Information 6.6.2 Mylan Pharmaceuticals Overview 6.6.3 Mylan Pharmaceuticals Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.6.4 Mylan Pharmaceuticals Sulphonamides Product Description 6.6.5 Mylan Pharmaceuticals Recent Developments 6.7 Novartis International AG 6.7.1 Novartis International AG Corporation Information 6.7.2 Novartis International AG Overview 6.7.3 Novartis International AG Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.7.4 Novartis International AG Sulphonamides Product Description 6.7.5 Novartis International AG Recent Developments 6.8 Pfizer 6.8.1 Pfizer Corporation Information 6.8.2 Pfizer Overview 6.8.3 Pfizer Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.8.4 Pfizer Sulphonamides Product Description 6.8.5 Pfizer Recent Developments 6.9 Par Pharmaceutical 6.9.1 Par Pharmaceutical Corporation Information 6.9.2 Par Pharmaceutical Overview 6.9.3 Par Pharmaceutical Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.9.4 Par Pharmaceutical Sulphonamides Product Description 6.9.5 Par Pharmaceutical Recent Developments 6.10 Roche Holding AG 6.10.1 Roche Holding AG Corporation Information 6.10.2 Roche Holding AG Overview 6.10.3 Roche Holding AG Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.10.4 Roche Holding AG Sulphonamides Product Description 6.10.5 Roche Holding AG Recent Developments 6.11 Sanofi Aventis 6.11.1 Sanofi Aventis Corporation Information 6.11.2 Sanofi Aventis Overview 6.11.3 Sanofi Aventis Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.11.4 Sanofi Aventis Sulphonamides Product Description 6.11.5 Sanofi Aventis Recent Developments 6.12 Stiefel Laboratories 6.12.1 Stiefel Laboratories Corporation Information 6.12.2 Stiefel Laboratories Overview 6.12.3 Stiefel Laboratories Sulphonamides Sales and Revenue in United States Market (2016-2021) 6.12.4 Stiefel Laboratories Sulphonamides Product Description 6.12.5 Stiefel Laboratories Recent Developments 7 United States Sulphonamides Production Capacity, Analysis 7.1 United States Sulphonamides Production Capacity, 2016-2027 7.2 Sulphonamides Production Capacity of Key Manufacturers in United States Market 8 Key Market Trends, Opportunity, Drivers and Restraints 8.1 Market Opportunities & Trends 8.2 Market Drivers 8.3 Market Restraints 9 Sulphonamides Supply Chain Analysis 9.1 Sulphonamides Industry Value Chain 9.2 Sulphonamides Upstream Market 9.3 Sulphonamides Downstream and Clients 9.4 Marketing Channels Analysis 9.4.1 Marketing Channels 9.4.2 Sulphonamides Distributors and Sales Agents in United States Market 10 Conclusion 11 Appendix 11.1 Note 11.2 Examples of Clients 11.3 Author Details 11.4 Disclaimer

List of Tables Table 1. Key Players of Sulphonamides in United States Market Table 2. Top Sulphonamides Players in United States Market, Ranking by Revenue (2019) Table 3. United States Sulphonamides Revenue by Companies, (US$, Mn), 2016-2021 Table 4. United States Sulphonamides Revenue Share by Companies, 2016-2021 Table 5. United States Sulphonamides Sales by Companies, (K MT), 2016-2021 Table 6. United States Sulphonamides Sales Share by Companies, 2016-2021 Table 7. Key Manufacturers Sulphonamides Price (2016-2021) & (USD/MT) Table 8. Manufacturers Sulphonamides Product Type Table 9. List of Tier 1 Sulphonamides Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Sulphonamides Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. Major Manufacturers of Orally Absorbable Sulfonamide Table 12. Major Manufacturers of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Table 13. By Type – United States Sulphonamides Revenue, (US$, Mn), 2021 & 2027 Table 14. By Type - United States Sulphonamides Revenue (US$, Mn), 2016-2021 Table 15. By Type - United States Sulphonamides Revenue (US$, Mn), 2022-2027 Table 16. By Type - United States Sulphonamides Sales (K MT), 2016-2021 Table 17. By Type - United States Sulphonamides Sales (K MT), 2022-2027 Table 18. By Application – United States Sulphonamides Revenue, (US$, Mn), 2021 VS 2027 Table 19. By Application - United States Sulphonamides Revenue (US$, Mn), 2016-2021 Table 20. By Application - United States Sulphonamides Revenue (US$, Mn), 2022-2027 Table 21. By Application - United States Sulphonamides Sales (K MT), 2016-2021 Table 22. By Application - United States Sulphonamides Sales (K MT), 2022-2027 Table 23. Abbott Laboratories Corporation Information Table 24. Abbott Laboratories Description and Major Businesses Table 25. Abbott Laboratories Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 26. Abbott Laboratories Sulphonamides Product Table 27. Abbott Laboratories Recent Developments Table 28. Boehringer Ingelheim Pharmaceuticals Corporation Information Table 29. Boehringer Ingelheim Pharmaceuticals Description and Major Businesses Table 30. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 31. Boehringer Ingelheim Pharmaceuticals Sulphonamides Product Table 32. Boehringer Ingelheim Pharmaceuticals Recent Developments Table 33. Bayer AG Corporation Information Table 34. Bayer AG Description and Major Businesses Table 35. Bayer AG Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 36. Bayer AG Sulphonamides Product Table 37. Bayer AG Recent Developments Table 38. GlaxoSmithKline Corporation Information Table 39. GlaxoSmithKline Description and Major Businesses Table 40. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 41. GlaxoSmithKline Sulphonamides Product Table 42. GlaxoSmithKline Recent Developments Table 43. King Pharmaceuticals Corporation Information Table 44. King Pharmaceuticals Description and Major Businesses Table 45. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 46. King Pharmaceuticals Sulphonamides Product Table 47. King Pharmaceuticals Recent Developments Table 48. Mylan Pharmaceuticals Corporation Information Table 49. Mylan Pharmaceuticals Description and Major Businesses Table 50. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 51. Mylan Pharmaceuticals Sulphonamides Product Table 52. Mylan Pharmaceuticals Recent Developments Table 53. Novartis International AG Corporation Information Table 54. Novartis International AG Description and Major Businesses Table 55. Novartis International AG Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 56. Novartis International AG Sulphonamides Product Table 57. Novartis International AG Recent Developments Table 58. Pfizer Corporation Information Table 59. Pfizer Description and Major Businesses Table 60. Pfizer Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 61. Pfizer Sulphonamides Product Table 62. Pfizer Recent Developments Table 63. Par Pharmaceutical Corporation Information Table 64. Par Pharmaceutical Description and Major Businesses Table 65. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 66. Par Pharmaceutical Sulphonamides Product Table 67. Par Pharmaceutical Recent Developments Table 68. Roche Holding AG Corporation Information Table 69. Roche Holding AG Description and Major Businesses Table 70. Roche Holding AG Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 71. Roche Holding AG Sulphonamides Product Table 72. Roche Holding AG Recent Developments Table 73. Sanofi Aventis Corporation Information Table 74. Sanofi Aventis Description and Major Businesses Table 75. Sanofi Aventis Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 76. Sanofi Aventis Sulphonamides Product Table 77. Sanofi Aventis Recent Developments Table 78. Stiefel Laboratories Corporation Information Table 79. Stiefel Laboratories Description and Major Businesses Table 80. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021) Table 81. Stiefel Laboratories Sulphonamides Product Table 82. Stiefel Laboratories Recent Developments Table 83. Sulphonamides Production Capacity (K MT) of Key Manufacturers in United States Market, 2019-2021 (K MT) Table 84. United States Sulphonamides Capacity Market Share of Key Manufacturers, 2019-2021 Table 85. Sulphonamides Market Opportunities & Trends in United States Market Table 86. Sulphonamides Market Drivers in United States Market Table 87. Sulphonamides Market Restraints in United States Market Table 88. Sulphonamides Raw Materials Table 89. Sulphonamides Raw Materials Suppliers in United States Market Table 90. Typical Sulphonamides Downstream Table 91. Sulphonamides Downstream Clients in United States Market Table 92. Sulphonamides Distributors and Sales Agents in United States Market List of Figures Figure 1. Sulphonamides Product Picture Figure 2. Sulphonamides Segment by Type Figure 3. Sulphonamides Segment by Application Figure 4. United States Sulphonamides Market Overview: 2020 Figure 5. United States Sulphonamides Market Size: 2021 VS 2027 (US$, Mn) Figure 6. United States Sulphonamides Revenue, 2016-2027 (US$, Mn) Figure 7. Sulphonamides Sales in United States Market: 2016-2027 (K MT) Figure 8. The Top 3 and 5 Players Market Share by Sulphonamides Revenue in 2020 Figure 9. Orally Absorbable Sulfonamide Product Picture Figure 10. Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine) Product Picture Figure 11. Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide) Product Picture Figure 12. By Type - United States Sulphonamides Sales Market Share, 2016-2027 Figure 13. By Type - United States Sulphonamides Revenue Market Share, 2016-2027 Figure 14. By Type - United States Sulphonamides Price (USD/MT), 2016-2027 Figure 15. Skin Infections Figure 16. Gastro Intestinal Tract (GIT) Infection Figure 17. Meningitis Figure 18. By Application - United States Sulphonamides Sales Market Share, 2016-2027 Figure 19. By Application - United States Sulphonamides Revenue Market Share, 2016-2027 Figure 20. By Application - United States Sulphonamides Price (USD/MT), 2016-2027 Figure 21. Abbott Laboratories Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Boehringer Ingelheim Pharmaceuticals Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 23. Bayer AG Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 24. GlaxoSmithKline Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 25. King Pharmaceuticals Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 26. Mylan Pharmaceuticals Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 27. Novartis International AG Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 28. Pfizer Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 29. Par Pharmaceutical Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 30. Roche Holding AG Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 31. Sanofi Aventis Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 32. Stiefel Laboratories Sulphonamides Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 33. United States Sulphonamides Production Capacity (K MT), 2016-2027 Figure 34. Sulphonamides Industry Value Chain Figure 35. Marketing Channels

Abbott Laboratories Boehringer Ingelheim Pharmaceuticals Bayer AG GlaxoSmithKline King Pharmaceuticals Mylan Pharmaceuticals Novartis International AG Pfizer Par Pharmaceutical Roche Holding AG Sanofi Aventis Stiefel Laboratories